Cargando…
CXCR3 mediates ascites-directed tumor cell migration and predicts poor outcome in ovarian cancer patients
Intraabdominal tumor dissemination is a major hallmark of epithelial ovarian cancer (EOC), but the underlying mechanisms have not been fully elucidated. The CXCR3 chemokine receptor supports migration of tumor cells to metastatic sites, but its role in ovarian cancer metastasis is largely unknown. H...
Autores principales: | Windmüller, C, Zech, D, Avril, S, Boxberg, M, Dawidek, T, Schmalfeldt, B, Schmitt, M, Kiechle, M, Bronger, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523062/ https://www.ncbi.nlm.nih.gov/pubmed/28504691 http://dx.doi.org/10.1038/oncsis.2017.29 |
Ejemplares similares
-
CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer
por: Bronger, Holger, et al.
Publicado: (2016) -
Induction of cathepsin B by the CXCR3 chemokines CXCL9 and CXCL10 in human breast cancer cells
por: Bronger, Holger, et al.
Publicado: (2017) -
Modulation of CXCR3 ligand secretion by prostaglandin E(2 )and cyclooxygenase inhibitors in human breast cancer
por: Bronger, Holger, et al.
Publicado: (2012) -
Increased PDGFR-beta and VEGFR-2 protein levels are associated with resistance to platinum-based chemotherapy and adverse outcome of ovarian cancer patients
por: Avril, Stefanie, et al.
Publicado: (2017) -
Improved migration of tumor ascites lymphocytes to ovarian cancer microenvironment by CXCR2 transduction
por: Idorn, Manja, et al.
Publicado: (2017)